171 related articles for article (PubMed ID: 8914772)
1. A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein.
Luo Y; Szilvasi A; Chen X; DeWolf WC; O'Donnell MA
Clin Diagn Lab Immunol; 1996 Nov; 3(6):761-8. PubMed ID: 8914772
[TBL] [Abstract][Full Text] [Related]
2. Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
Sun E; Fan X; Wang L; Lei M; Zhou X; Liu C; Lu B; Nian X; Sun Y; Han R
Oncol Rep; 2015 Jul; 34(1):183-94. PubMed ID: 25998552
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model.
Chade DC; Borra RC; Nascimento IP; Villanova FE; Leite LC; Andrade E; Srougi M; Ramos KL; Andrade PM
J Exp Clin Cancer Res; 2008 Nov; 27(1):78. PubMed ID: 19040745
[TBL] [Abstract][Full Text] [Related]
5. Construction of recombinant human IFNα-2b BCG and its antitumor effects on bladder cancer cells in vitro.
Sun E; Nian X; Liu C; Fan X; Han R
Genet Mol Res; 2015 Apr; 14(2):3436-49. PubMed ID: 25966110
[TBL] [Abstract][Full Text] [Related]
6. A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity.
Yang X; Bao L; Deng Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):511-8. PubMed ID: 21676888
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma.
Arnold J; de Boer EC; O'Donnell MA; Böhle A; Brandau S
J Immunother; 2004; 27(2):116-23. PubMed ID: 14770083
[TBL] [Abstract][Full Text] [Related]
8. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH
Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
10. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
Bao L; Chen W; Zhang H; Wang X
Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
[TBL] [Abstract][Full Text] [Related]
11. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Th1 lung immunity induced by recombinant Mycobacterium bovis Bacillus Calmette-Guerin attenuates airway allergic disease.
Christ AP; Rodriguez D; Bortolatto J; Borducchi E; Keller A; Mucida D; Silva JS; Leite LC; Russo M
Am J Respir Cell Mol Biol; 2010 Aug; 43(2):243-52. PubMed ID: 19805481
[TBL] [Abstract][Full Text] [Related]
13. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
14. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing fusion protein IL-2-ESAT-6.
Fan XL; Yu TH; Gao Q; Yao W
Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):683-90. PubMed ID: 17033714
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
Yu DS; Lee CF; Hsieh DS; Chang SY
Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of interleukin-2 and green fluorescent protein reporter in mycobacteria: in vivo application for monitoring antimycobacterial immunity.
Luo Y; Chen X; Szilvasi A; O'Donnell MA
Mol Immunol; 2000 Jun; 37(9):527-36. PubMed ID: 11163402
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages.
Soualhine H; Deghmane AE; Sun J; Mak K; Talal A; Av-Gay Y; Hmama Z
J Immunol; 2007 Oct; 179(8):5137-45. PubMed ID: 17911599
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
19.
Rodriguez D; Goulart C; Pagliarone AC; Silva EP; Cunegundes PS; Nascimento IP; Borra RC; Dias WO; Tagliabue A; Boraschi D; Leite LCC
Front Immunol; 2019; 10():1460. PubMed ID: 31297119
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
Takeuchi A; Eto M; Tatsugami K; Shiota M; Yamada H; Kamiryo Y; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Takahashi R; Yokomizo A; Ohara N; Yoshikai Y
Int Immunopharmacol; 2016 Jun; 35():327-331. PubMed ID: 27093372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]